Published 6 July 2009, doi:10.1136/bmj.b2725
Cite this as: BMJ 2009;339:b2725

News

US senator seeks information about medical faculty links to drug industry

Janice Hopkins Tanne

1 New York

The first 150 words of the full text of this article appear below.

Senator Chuck Grassley has asked 23 US medical schools for information about their policies on conflicts of interest and requirements for disclosure of financial ties between staff members and drug firms.

Senator Grassley, an Iowa Republican who is the leading minority member on the Senate Committee on Finance, wrote to 23 medical schools that had not completed a survey by the American Medical Student Association.

The senator is active in investigating ties between medical schools, leading doctors, and drug and device manufacturers. He is particularly interested in doctors who receive grants from the National Institutes of Health who may also have relationships with drug, device, or biotechnology companies.

Academic institutions that receive funding from the National Institutes of Health (NIH) are required to track and report such financial relationships, but the senator says he has found enforcement of these regulations to be "either lax or in violation." The NIH awards . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Access jobs at BMJ Careers
Whats new online at Student BMJ